Alterity Therapeutics Ltd News

Press Release: Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer

Dow JonesSep 30 19:35

Alterity Therapeutics Names New CFO; Shares Down 25%

MT NewswiresSep 30 09:38

Alterity Therapeutics Ltd: Annual Report 2024

ASXSep 26 11:09 · Announcements

Alterity Therapeutics Ltd: Appendix 4E Preliminary Final Report

Aug 29 11:23 · Announcements

Alterity Therapeutics on Track to Complete Phase Two Trial of Lead Drug Candidate in November

MT NewswiresMay 8 10:45

Press Release: Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund

Dow JonesMar 26 22:25

Alterity Therapeutics Receives AU$3.9 Million R&D Tax Refund

MT NewswiresMar 26 11:43

Genetic Technologies Appoints CFO

MT NewswiresMar 25 15:04

Alterity Therapeutics Price Target Maintained With a $4.00/Share by Benchmark

Dow JonesMar 7 21:53

Alterity Therapeutics Raises AU$3.3 Million for Clinical Trials; Shares Fall 20%

MT NewswiresFeb 23 11:12

Alterity Therapeutics Advances Phase Two Multiple System Atrophy Trial Following Committee Recommendation

MT NewswiresFeb 6 14:10

Alterity Therapeutics Completes Securities Purchase Plan

MT NewswiresFeb 2 10:06

Alterity Dispatches Documents Of Planned Share Sale

MT NewswiresJan 10 21:32

Alterity Therapeutics Concludes Second Tranche of Placement of AU$3.5 Million; Shares Plunge 20%

MT NewswiresJan 8 11:41

Alterity Therapeutics to Raise Up to AU$2 Million Via Share Purchase Plan

MT NewswiresDec 29, 2023 14:27

Alterity: Andrews to Support Company During Transition>ATHE

Dow JonesDec 21, 2023 13:32

Alterity: Hains Follows Resignation of Kathryn Andrews, CFO Since 2014 >ATHE

Dow JonesDec 21, 2023 13:32

Alterity: CFO Appointment Effective Jan 31, 2024 >ATHE

Dow JonesDec 21, 2023 13:31

Press Release: Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer

Dow JonesDec 21, 2023 13:30

Alterity Therapeutics Shares Up Fivefold on New Parkinson's Drug Data

Dow JonesDec 4, 2023 20:45